Literature DB >> 23145561

Industrialized research in the BJCP: a neo-Luddite view.

Adam F Cohen, James M Ritter.   

Abstract

Mesh：

Year:  2012        PMID： 23145561      PMCID： PMC3522802          DOI： 10.1111/bcp.12000

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  Developing drug prototypes: pharmacology replaces safety and tolerability?

Authors:  Adam F Cohen
Journal:  Nat Rev Drug Discov       Date:  2010-09-17       Impact factor: 84.694

2.  Improving the quality of drug research or simply increasing its cost? An evidence-based study of the cost for data monitoring in clinical trials.

Authors:  Esther Pronker; Bart F Geerts; Adam Cohen; Herman Pieterse
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

4.  Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

Authors:  A F Cohen; L Ashby; D Crowley; G Land; A W Peck; A A Miller
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

5.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  5 in total
  2 in total

1.  On authorship in the BJCP.

Authors:  Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2017-10       Impact factor: 4.335

2.  Goodbye to all that.

Authors:  Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.